glp-1 x gip Biology of Incretins: and Dual GIP/GLP-1 receptor agonists: New

[DOI] [PubMed] [Google Scholar] [3].Basit A, Fawwad A, Qureshi H, et al

That study will provide insights into the potential of GLP-1 RAs to modify the disease course in HFpEF patients

These medications often reduce appetite and slow digestion, both of which can be particularly concerning for ED patients due to the potential for nutritional deficits and disordered eating behaviors

Case 1: A female with a history of Roux-en-Y Gastric Bypass surgery, pre-surgical BMI of 68, and metabolic syndrome, was prescribed GLP-1 therapy to aid further weight loss post-surgery

Its essential to discuss risk and benefits with your healthcare provider and to be aware of the potential side effect in order to manage them effectively: Nausea and vomiting : These are the most common side effects and usually decrease over time